A Study to Evaluate Bioequivalence and Adhesion of a Transdermal Contraceptive Patch Manufactured With Newly Sourced Adhesive Components and Currently Marketed EVRA in Healthy Adult Women

NCT03274297 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

70

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: EVRA patch (NGMN+EE) (Treatment A) (Reference)
DRUG: HMW PIB patch (NGMN+EE) (Treatment B) (Test)

Sponsor

Janssen Research & Development, LLC